Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose. The Company developed NARCANÂŽ (naloxone hydrochloride) Nasal Spray (âNARCANÂŽâ), a treatment to reverse opioid overdose. This product was conceived and developed by the Company, licensed to Adapt Pharma Operations Limited (âAdaptâ), an Ireland based pharmaceutical company in December 2014 and approved by the U.S. Food and Drug Administration (âFDAâ) in November 2015. It is marketed by Adapt. In October 2018, Emergent BioSolutions, Inc. ("EBS") completed its acquisition of Adapt. The Company's current pipeline includes medicines in development for Opioid Overdose Reversal (âOORâ), Alcohol Use Disorder (âAUDâ), Opioid Use Disorder (âOUDâ), and Acute Cannabinoid Overdose (âACOâ). The Company is also pursuing other treatment opportunities within the addiction and drug overdose field. Source
No articles found.
NanoString Technologies is a leading provider of life science tools for translatio...
NanoString Technologies is a leading provider o...
We are a network of full-service medical equipment companies that use tailored pro...
We are a network of full-service medical equipm...
We are a clinical stage biopharmaceutical company focused on the discovery, develo...
We are a clinical stage biopharmaceutical compa...
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse p...
Oncternal Therapeutics is a clinical-stage onco...
We are a clinical stage biopharmaceutical company focused on the discovery, develo...
We are a clinical stage biopharmaceutical compa...
Radius is a science-driven fully integrated biopharmaceutical company that is comm...
Radius is a science-driven fully integrated bio...
Titan is a specialty pharmaceuticals company that develops therapeutics for select...
Titan is a specialty pharmaceuticals company th...
Join the National Investor Network and get the latest information with your interests in mind.